Terms: = Uterine cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E
95 results:
1. High-grade endometrial stromal sarcoma displaying immunohistochemical expression of BCOR-A report of two cases of a novel tumor entity.
Wagh V; Menon S; Maheshwari A; Gupta S; Deodhar KK; Rekhi B
Indian J Pathol Microbiol; 2023; 66(4):829-833. PubMed ID: 38084541
[TBL] [Abstract] [Full Text] [Related]
2. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
Kikuchi A; Yoshida H; Tsuda H; Nishio S; Suzuki S; Takehara K; Kino N; Sumi T; Kato K; Yokoyama M; Nakamura K; Takano M; Sato S; Kato H; Tamate M; Horie K; Kato T; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Yaegashi N; Satoh T
Gynecol Oncol; 2023 Sep; 176():82-89. PubMed ID: 37478616
[TBL] [Abstract] [Full Text] [Related]
3. uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring ywhae::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
Devins KM; Attygalle AD; Croce S; Vroobel K; Oliva E; McCluggage WG
Am J Surg Pathol; 2023 Jun; 47(6):717-724. PubMed ID: 37032555
[TBL] [Abstract] [Full Text] [Related]
4. Breast metastasis in high-grade endometrial stromal sarcoma (HG-ESS) with BCOR rearrangement: a case report of a novel metastatic site.
Fong A; Offman S
Diagn Pathol; 2023 Mar; 18(1):34. PubMed ID: 36864468
[TBL] [Abstract] [Full Text] [Related]
5. High-Grade Endometrial Stromal Sarcomas With ywhae::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker.
Kommoss FKF; Mar LM; Howitt BE; Hanley K; Turashvilli G; Buslei R; Irving JA; Dickson BC; Koelsche C; Sinn HP; Schirmacher P; von Deimling A; Chiang S; McCluggage WG; Croce S; Stewart CJR; Lee CH
Mod Pathol; 2023 Mar; 36(3):100044. PubMed ID: 36788095
[TBL] [Abstract] [Full Text] [Related]
6. Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma.
Kang N; Zhang Y; Guo S; Chen R; Kong F; Wang S; Yuan M; Chen R; Shen D; Wang J
Cancer Res Treat; 2023 Jul; 55(3):978-991. PubMed ID: 36731460
[TBL] [Abstract] [Full Text] [Related]
7. NCOA1/2/3 rearrangements in uterine tumor resembling ovarian sex cord tumor: A clinicopathological and molecular study of 18 cases.
Lu B; Xia Y; Chen J; Tang J; Shao Y; Yu W
Hum Pathol; 2023 May; 135():65-75. PubMed ID: 36646185
[TBL] [Abstract] [Full Text] [Related]
8. Myeloid sarcoma arising at the uterine cervix in a patient with intestinal Behçet's disease and concurrent myelodysplastic syndrome: A case report.
Choi HY; Pak MG; Park JW
Medicine (Baltimore); 2022 Oct; 101(43):e31559. PubMed ID: 36316914
[TBL] [Abstract] [Full Text] [Related]
9. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment.
Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X
Front Public Health; 2022; 10():979933. PubMed ID: 36203656
[TBL] [Abstract] [Full Text] [Related]
10. An Unusual Benign uterine Stromal Spindle Cell Tumor Harboring JAZF1::BCORL1.
Rodriguez Pena MDC; Mubeen A; Harada S; Prieto Granada CN
Int J Gynecol Pathol; 2023 May; 42(3):319-324. PubMed ID: 35838627
[TBL] [Abstract] [Full Text] [Related]
11. Genetic variation of
Jin X; Dai M; Zhou Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 47(1):101-108. PubMed ID: 35545369
[No Abstract] [Full Text] [Related]
12. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis.
Alkanat NE; Uner A; Usubutun A
Int J Surg Pathol; 2023 Aug; 31(5):521-531. PubMed ID: 35506912
[No Abstract] [Full Text] [Related]
13. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.
Kommoss FKF; Chiang S; Köbel M; Koelsche C; Chang KT; Irving JA; Dickson B; Thiryayi S; Rouzbahman M; Rasty G; von Deimling A; Lee CH; Turashvili G
Am J Surg Pathol; 2022 Aug; 46(8):1142-1152. PubMed ID: 35499168
[TBL] [Abstract] [Full Text] [Related]
14. [Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification].
Mayr D; Horn LC; Hiller GGR; Höhn AK; Schmoeckel E
Pathologe; 2022 May; 43(3):183-195. PubMed ID: 35362728
[TBL] [Abstract] [Full Text] [Related]
15. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group.
Yoshida H; Kikuchi A; Tsuda H; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Shikama A; Kogata Y; Terao Y; Tanikawa M; Yasuoka T; Chiyoda T; Miyamoto T; Okadome M; Nakamura T; Enomoto T; Konno Y; Yahata H; Hirata Y; Aoki Y; Tokunaga H; Usui H; Yaegashi N
Hum Pathol; 2022 Jun; 124():24-35. PubMed ID: 35339567
[TBL] [Abstract] [Full Text] [Related]
16. JAZF1, ywhae and BCOR gene translocation in primary extrauterine low-grade and high-grade endometrial stromal sarcomas.
Sun L; Zhao W; Zhao Z; Zhu Y
Histopathology; 2022 Apr; 80(5):809-819. PubMed ID: 34843125
[TBL] [Abstract] [Full Text] [Related]
17. Description of a Novel ERBB4 -rearranged uterine Sarcoma.
Lim SH; Mansor SB; Kathirvel R; Kuick CH; Lim-Tan SK; McCluggage WG
Int J Gynecol Pathol; 2022 Sep; 41(5):508-513. PubMed ID: 34570017
[TBL] [Abstract] [Full Text] [Related]
18. LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies.
Li C; Wang C
J Zhejiang Univ Sci B; 2021 Aug; 22(8):633-646. PubMed ID: 34414699
[TBL] [Abstract] [Full Text] [Related]
19. The value of immunohistochemical methods in diagnosing mesenchymal tumours of the uterus.
Dundr P; Gregová M; Němejcová K; Bártů M; Bennett RJ; Stružinská I
Cesk Patol; 2021; 57(2):86-95. PubMed ID: 34275318
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of Inducible Nitric Oxide Synthase (iNOS) by Andrographolide and
Pasha A; Kumbhakar DV; Doneti R; Kumar K; Dharmapuri G; Poleboyina PK; S K H; Basavaraju P; Pasumarthi D; S D A; Soujanya P; Arnold Emeson I; Bodiga V; Pawar SC
Oxid Med Cell Longev; 2021; 2021():6692628. PubMed ID: 33815659
[TBL] [Abstract] [Full Text] [Related]
[Next]
